Remepy logo

Remepy

Remepy is biotechnology research pioneering hybrid drugs. The company believes that in the future, software applications will become an integral part of treatments offered by Pharma companies in the form of Hybrid Drugs. These will include both a software component and a traditional drug component - influencing patients via Hybrid Mechanisms of Action™. It was founded in 2022 and is located in Ramat Gan, Tel Aviv.

https://www.remepy.com/

Company Details

Founded

2022

Employees

Between 20 - 100 employees

Raised

$15,000,000

Public

No

Acquired

No

CEO

Or ShovalOr Shoval

Founders

Michal Tsur
Michal Tsur
Or Shoval
Or Shoval
Amir Amedi
Amir Amedi

Company Collections

These are collections Remepy is a part of. Click on the collection name to view similar companies.

Remepy's Industries

Total Amount Raised: $15,000,000

Remepy Funding Rounds

  • Seed

    $10,000,000

    Seed Investors

    NFX
    fresh.fund
    Vine Ventures
    Supernode Ventures
    Firstime
    97212 Ventures
    Samsung Next
    TechAviv
    PsyMed Ventures
    Stage Next Ventures

  • Seed

    $5,000,000

    Seed Investors

    Flatiron Investors
    Samsung Next
Funding info provided by Diffbot.

Remepy Reviews

0 out of 5 stars

Based on 0 reviews

Review data

Share your thoughts

Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Remepy.

Recent reviews